1262 results about "Mastitis" patented technology

A nursing bra comprised of two cups with an outer pocket/flap in each cup for holding a thin circular heating/cooling device in place. This pocket is a full piece of fabric with an opening at the upper center portion of the garment that holds the heating/cooling device in place. The heating/cooling device provides relief from engorgement, plugged ducts, mastitis and other general nursing pain. There is also a rear panel comprised of two cups with openings in each cup for nursing a baby. The front and rear panel coexist, forming a supportive and comfortable bra. The removable front, outer panel is connected to the rear panel at the base, which allows for the upper portion of the front panel to be lowered allowing the nipple, and surrounding area of the woman's breast to be exposed for nursing.

A method of milk extraction system may include massaging a posterior of a breast. Massaging and collecting milk may optionally be performed simultaneously. A posterior massager may also be used and/or mounted separately from a collection unit. In some embodiments the massager may be used to improve milk collection and/or alleviate breast ailments for example engorgement, plugged ducts, and/or mastitis. A collection flange may include an air inlet manifold, to mix air and milk. Optionally as air is drawn along a tube by a vacuum, milk may be entrained in the airstream and brought towards a collection vessel. The system may include automated tracking of milk production and/or consumption.

Selected strains of Lactobacillus and products containing cells of the selected strains to improve breast milk for feeding to babies, more precisely to increase the levels of the anti-inflammatory cytokine IL10 in the milk and reduce the risk that the feeding baby will develop allergies and simultaneously reduce the cause and thereby the amount of TGF-beta-2 in the milk, thus resulting in reduced risk for the lactating mother to develop mastitis.

A method is provided for treatment of an infective condition in an udder of a milk producing animal. The method comprises intramammary administration of an antibacterial agent in combination therapy with a selective COX-2 inhibitor in therapeutically effective amounts of each. Also provided is a pharmaceutical composition comprising an antibacterial agent and a selective COX-2 inhibitor, together with one or more excipients, in a dosage form suitable for intramammary administration to a milk producing animal.

A teat dip formula is disclosed for use on dairy animals with the objective of reducing or preventing mastitis. The teat dip formula preferably includes up to about 2% of peracetic acid in solution made by mixing acetic acid, hydrogen peroxide, and from up to about 5% by weight of composition of a thickening agent. Other constituents of the formula may include effective amounts of a skin conditioning agent or agents, a surfactant or surfactants and urea. A method of preparing and applying the formula is disclosed.

The invention discloses a special gestation compound feed for sows at later stage of pregnancy. The special gestation compound feed is prepared from the following raw materials: corn, bran, rice bran meal, DDGS (dried distiller grains with soluble), swelling soya dregs, swelling soybean flour, fermented soybean meal, compound sugar, mountain flour, calcium hydrogen phosphate, choline chloride, common salt, compound premix, L-lysine hydrochloride, L-threonine, acidifier, clostridium butyricum and yeast cell wall polysaccharides. The invention, starts from nutrition of the sows at the later stage of the pregnancy, gives consideration to the growth of fetuses and the physiological characteristics of the sows per se, designs daily ration with high protein, high amino acid and low energy, adds the compound sugar constituted by different monosaccharides and disaccharides, and can provide energy which can be utilized quickly and improve the birth weight and the uniformity of piglets; and by adding the clostridium butyricum and the yeast cell wall polysaccharides, the special gestation compound feed can improve the intestinal health of the sows, improve immunity, regulate intestinal peristalsis, reduce the constipation incidence of the sows, shorten the labor stage of the sows, reduce the incidence rate of mastitis and endometritis of the sows, and assist the sows in rapid postpartum recovery.

The invention discloses a Chinese traditional herbal medicine foodstuff additive, Xia'ansan, and a preparation method and applications thereof. The additive is made from astragalus root, Chinese angilica, tube of dwarf lilyturf, dried tangerine peel, green tangerine peel, vegetable sponge, dandelion, fructus forsythiae, radix bupleuri, honeysuckle vine, complete Trichosanthes kirilowii Maxim, Saponaria vaccaria, fructus liquidambaris, and liquorice. The preparation method of the invention is that: the 14 materials are air-cured and dried, dried at 60 DEG C, and then crushed and sifted by 100-mesh sifter, and finally subpackaged. The additive can be blended into the foodstuff for feeding cow, which has heat and stress resistance function to cows giving milk, thus enhancing milk yield. The additive can be used in a hot season for 30 to 45 days in a dosage of 150 to 200g per day for one cow, which can ensure that cow maintains a milk yield increased by more than 10% in 120 days, and can dramatically reduce the incidences of mastitis, endometritis and hoof disease.

Improved film-forming skin protectant compositions are provided which are capable of forming a long-lasting elastic barrier film when applied to skin; the compositions have particular utility as barrier teat dips, for protecting cows against mastitis, especially during their susceptible non-lactating periods. The compositions include a film-forming component (preferably a mixture of polyether polyurethane and nitrocellulose) dispersed in a compatible carrier and further having a quantity of a tackifier resin incorporated therein in order to increase the time of adherence of the composition to skin, as compared with an otherwise identical composition without a tackifier resin. The compositions may also include a germicide (e.g., chlorhexidine diacetate), and a coloring dye.

Systems and methods for improving the health and wellbeing of subjects in an industrial setting are disclosed. The systems may include a camera arranged so as to observe one or more features of a subject, and a processor, coupled to the camera, the processor configured to analyze one or more images obtained therefrom, to extract one or more features from the image(s) of the subject, and to analyze one or more of the features, or sub features nested therein to predict an outcome of a state of the subject. In particular the system may be configured to generate a diagnostic signal (e.g. an outcome, fever, mastitis, virus, bacterial infection, rut, etc.) based upon the analysis.

A veterinary pharmaceutical formulation containing meloxicam or a pharmacologically acceptable meloxicam salt of an organic or inorganic base and one or more vehicles having analgesic efficacy for the treatment of inflammatory painful diseases, particularly for the treatment of mild or moderate mastitis cases. The treatment leads to an effective long lasting reduction of a hypersensitive state associated with inflammatory pain in mild or moderate mastitis cases, particularly chronic states thereof.

The present invention provides peptides and analogs and derivatives thereof having antimicrobial activity at least against Streptococcus uberis for the treatment of a range of infectious disease mastitis, otitis externa, clostridial intestinal disease and respiratory disease.

The invention discloses a biological feed at the later period of pregnancy and the lactation period of sows. The feed comprises the following components in percentage: 68.60% of corns in northeastern part, 6.10% of bran, 13.97% of bean pulp, 3.00% of fermented bean pulp, 3.00% of fish meal in Zhejiang, 1.00% of phospholipid oil, 0.02% of probiotics, 0.05% of angel yeast, 1.46% of mountain flour, 0.62% of calcium hydrophosphate, 0.28% of edible salt, 0.02% of phytase, 0.02% of concentrated enzyme, 0.24% of65% lysine, 0.12% of choline chloride, 1.00% of premix, 0.5% of traditional Chinese medicine additives, wherein the components are totally 100%. According to the invention, according to the physiology and reproduction characteristics of the later period of pregnancy and lactation period of sows, the traditional Chinese medicine additives are added in the feed; the lactation yield of sows is improved; the breast milk nutrition is increased, and the aims of sufficient milk quantity of sows, no weightlessness, mastitis prevention as well as high piglet rate of survival, high weight in weaning, and less death in weaning stress and having diarrhea are achieved.

The antimicrobial activity of bovine bactericidal/permeability-increasing protein (bBPI)-derived synthetic peptides against mastitis-causing Gram-negative bacteria was evaluated. Three peptides were synthesized with sequences corresponding to amino acids 65-99 (bBPI_65-99), 142-169 (bBPI_142-169), or the combination of amino acids 90-99 and 148-161 (bBPI_{90-99,148-161}) of bBPI. The bBPI_{90-99,148-161} peptide demonstrated the widest spectrum of antimicrobial activity, with minimum inhibitory (MIC) and bactericidal (MBC) concentration values ranging from 16-64 μg/ml against Escherichia coli, Klebsiella pneumoniae, and Enterobacter spp, and 64-128 μg/ml against Pseudomonas aeruginosa. None of the peptides exhibited any growth inhibitory effect on Serratia marcescens. The antimicrobial activity of bBPI_{90-99,148-161} was inhibited in milk, but preserved in serum. Finally, both bBPI_142-169 and bBPI_{90-99,148-161} were demonstrated to completely neutralize LPS. The peptide bBPI_{90-99,148-161} is a potent neutralizer of the highly pro-inflammatory molecule bacterial LPS and has antimicrobial activity against a variety of Gram-negative bacteria.

The present invention discloses a method for detection and prediction of mastitis. The method comprises the steps of determining the values of mastitis indicators and comparing the values with predetermined standards, wherein deviation from the standards provides a measure of mastitis.

A treatment composition for treating or preventing bovine mastitis, the treatment composition characterised in that it includes at least two components which have an isoelectric point of or above substantially 6.8 and is extracted from milk, or a milk derived substance.

A long-lasting persistent, uniform film-forming skin protecting germicidal composition provides a long-lasting persistent barrier film when applied to skin. The compositions have particular utility as barrier teat dips for protecting cows against mastitis. A barrier film-forming agent is selected from the modified or hydrolyzed polysaccharides, particularly a hydrolyzed or modified starch, such as dextrin and maltodextrin. The barrier film-forming agent is stably solubilized in a solvent that dries to form the long-lasting persistent uniform film over the animal skin. The compositions also contain antimicrobial agents that fight against microbes that manage to penetrate the protective barrier film. Particularly, advantageous is that all the materials used are safe food additive and cost effective over the traditional barrier film forming agents.

A method and pharmaceutical composition for ceasing milk production, for inducing involution, or for treating infection in a mammary gland of a lactating animal is described. The method is effected by direct administration of calcium chelators to the gland, or upon administration of enzymes which cause production of chelators in situ. The invention can be used to change the physiologic state of a single mammary gland of a lactating animal without significantly affecting the physiologic state of other mammary glands of the same animal. Changes resulting from use of the invention may be either transient or long lasting. The invention is expected to have uses in commercial agriculture and human medicine.

Method and apparatus for testing a milk for mastitis wherein the milk sample is admixed with a detergent under condition that increase the viscosity of the milk sample; the increased viscosity mixture is subjected to a further procedure for further increasing its viscosity; and the further increased viscosity mixture is then tested for an attribute of somatic cells, such as DNA. This determination is then used to establish if the cow from whom the milk came has mastitis.

The invention relates to a traditional Chinese medicine for curing mammary hyperplasia, which comprises oral administration Chinese traditional pills and external application plaster. The oral administration Chinese traditional pills comprise 23 Chinese herb medicines, while the external application plaster comprises 32 Chinese herb medicines. The ingredients of the traditional Chinese medicine formula is mixed compatibly and properly; the plaster and the oral administration pills of the invention can effectively cure the mammary hyperplasia caused by various reasons and has fast efficacy, short course of treatment, high cure rate and low cost. The traditional Chinese medicine of the invention has unique healing efficacy to breast adenofibroma, breast cancer, nipple discharge, mastalgia, mastitis, breast deformity, micromazia, osteomyelitis, femoral head necrosis, various sores, lymphoid tuberculosis and eye-mouth deviation.

The invention discloses a functional feed for preventing and treating mastitis in dairy cows and a preparation method of the feed. The functional feed contains the following raw materials in parts by weight: 0.2 to 0.5 part of probiotics, 40 to 60 parts of corn, 8 to 15 parts of wheat bran, 5 to 15 parts of dehulled soybean meal, 5 to 10 parts of corn distillers'grains, 5 to 15 parts of dephenolized cotton meal, 4 to 10 parts of cotton meal, 2 to 5 parts of shorts, 3 to 4 parts of calcium hydrogen phosphate, 1.5 to 2 parts of shorts and stone powders, 2 to 3 parts of rumen fat powders, 1.0 to1.5 parts of baking soda, 0.5 to 1.0 parts of magnesium oxide, 0.3 to 0.8 part of sodium chloride, 1 to 2 parts of molasses, 1 to 1.5 parts of premix for lactating cows and 0.5 to 1 part of sodium sulfate. The results of the study in dairy cows show that the functional feed can reduce the number of somatic cells of dairy cows and can effectively prevent the incidence and development of mastitis in dairy cows.

The present invention provides compositions and methods for the treatment of infection in a subject. More particularly, the invention provides a therapy for the treatment or prevention of mammary infections, such as bovine mastitis, comprising the topical administration to a subject of an anti-microbial agent and a phospholipid-containing skin conditioner.

The invention is directed to the use of a formulation containing meloxicam or a pharmacologically acceptable meloxicam salt of an organic or inorganic base, one or more vehicles and one or more suitable additives for preparing a veterinary medical composition for intramammary treatment of inflammatory diseases in mammals, particularly mastitis. The intramammary administration leads to an effective concentration in the target tissue, which is achieved very quickly.